单孔法全腔镜局部扩大切除术进行保乳手术的临床应用

doi:10.3969/j.issn.1006-7795.2016.03.016

首都医科大学学报 ›› 2016, Vol. 37 ›› Issue (3): 336-340.doi: 10.3969/j.issn.1006-7795.2016.03.016

单孔法全腔镜局部扩大切除术进行保乳手术的临床应用

王子函, 滕长胜, 葛智成, 张慧明, 苑著, 高银光, 张忠涛, 屈翔

首都医科大学附属北京友谊医院普外科, 北京 100050

收稿日期:2016-03-25 出版日期:2016-06-21 发布日期:2016-06-13
通讯作者: 屈翔 E-mail:qx3968@sina.com
基金资助:
北京市科委首都临床特色应用研究专项(Z141107002514120)。

Single port laparoscopic breast-conserving surgery in treatment of breast cancer

Wang Zihan, Teng Changsheng, Ge Zhicheng, Zhang Huiming, Yuan Zhu, Gao Yinguang, Zhang Zhongtao, Qu Xiang

Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China

Received:2016-03-25 Online:2016-06-21 Published:2016-06-13
Supported by:
This study was supported by Capital Characteristic Clinic Project of Beijing Municipal Science & Technology Commission(Z141107002514120).

摘要/Abstract

摘要： 目的探讨单孔法全腔镜局部扩大切除术进行保乳手术在乳腺癌治疗中的手术技巧和应用价值。方法总结2014年11月至2015年6月以早期乳腺癌行单孔法全腔镜局部扩大切除术进行保乳手术的23例患者的临床资料,对根治性、美容效果评分等进行评估。结果 23例患者均成功完成单孔法全腔镜局部扩大切除术。术后随访时间6~13个月(平均随访时间10.4个月),无局部复发或远处转移。术后3个月美容效果评分:非常满意20例(87.0%),比较满意3例(13.0%),无一般或不满意病例。术后无皮肤坏死、切口下方积液或血肿等合并症发生。结论单孔法全腔镜局部扩大切除术进行保乳手术可以在保证早期乳腺癌肿瘤根治性的同时,获得更好的美容效果。

关键词: 乳腺癌, 单孔腔镜手术, 保乳手术

Abstract: Objective To evaluate the curability and the aesthetic results of the single port laparoscopic breast-conserving surgery. Methods From November 2014 to June 2015, a total of 23 patients with breast cancer underwent single port laparoscopic breast-conserving surgery. All patients were diagnosed as early breast cancer, stage I and II. We estimate the radical and cosmetic result. Results Single port laparoscopic breast-conserving surgery was performed on 23 patients. There was no serious complication after surgery. The follow-up time was 23 months at maximum and 10.4 months on average. There was no locoregional recurrence or distant metastases. The postoperative esthetic results were excellent, most of patients expressed great satisfaction(20/23,87.0%). ConclusionSingle port laparoscopic breast-conserving surgery can be considered as a surgical procedure with good locoregional control, it can also provide esthetic advantages for patients with early breast cancer.

Key words: breast cancer, single port laparoscopic, breast conserving surgery

中图分类号:

R737.9

王子函, 滕长胜, 葛智成, 张慧明, 苑著, 高银光, 张忠涛, 屈翔. 单孔法全腔镜局部扩大切除术进行保乳手术的临床应用[J]. 首都医科大学学报, 2016, 37(3): 336-340.

Wang Zihan, Teng Changsheng, Ge Zhicheng, Zhang Huiming, Yuan Zhu, Gao Yinguang, Zhang Zhongtao, Qu Xiang. Single port laparoscopic breast-conserving surgery in treatment of breast cancer[J]. Journal of Capital Medical University, 2016, 37(3): 336-340.

参考文献

[1] Jason C Y, Weisi Y, Paul J C, et al. Equivalent survival with mastectomy or breast-conserving surgery plus radiation in young women aged<40 years with early-stage breast cancer: A National Registry-based Stage-by-Stage Comparison [J]. Clin Breast Cancer, 2015, 15(5): 390-397
[2] Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast [J]. N Engl J Med, 1981, 305(1):6-11.
[3] Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer [J]. N Engl J Med, 1985, 312(11):665-673.
[4] Jose V, Sara G, Oreste G. Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: a systematic meta-analysis comparing breast-conserving surgery versus mastectomy [J]. The Breast, 2015, 24 (3): 175-181
[5] 黎介寿,吴孟超,黄志强. 手术学全集.普通外科卷[M]. 北京:人民军医出版社,2003:105-111.
[6] Maurice Y Nahabedian. 乳房肿瘤整形外科学[M]. 北京:北京大学医学出版社,2012:45-68. [7] J Yamashita K. Cosmetic assessment [J]. J Jpn Soc Endosc Surg, 2005,10:165-170. [8] 李霓. 中国城乡女性乳腺癌发病趋势分析和预测[J]. 中华预防医学杂志, 2012, 46(8): 703-707. [9] J Aerts L, Christiaens M R, Enzlin P, et al. Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: A prospective controlled study[J]. The Breast, 2014, 23(5): 629-636
[10] Morris A D, Morris R D, Wilson J F et al. Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta analysis of 10-year survival[J]. Cancer J Sci Am, 1997, 3(1):6-12.
[11] Van Dongen J A. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial[J]. J Natl Cancer Inst Monogr, 1992,11:15-18.
[12] Lichter A S. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute [J]. J Clin Oncol, 1992, 10(6):976-983.
[13] Yamashita K S K. Endoscopic video-assisted breast surgery: procedures and short-term results[J]. J Nippon Med School, 2006, 73(4): 193.
[14] Langer I, Kocher T, Guller U, et al. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients[J]. Breast Cancer Res Treat, 2005, 90(1): 85-91.
[15] Nakajima H, Sakaquchi K, Mizwta N, et al. Video-assisted total glandectomy and immediate reconstruction for breast cancer[J]. Biomed Pharmacother, 2002, 56(1): 205-208.
[16] Kühn T, Santjohanser C, Koretz K, et al. Axilloscopy and endoscopic sentinel node detection in breast cancer patients[J]. Surgical Endoscopy, 2000, 14(6): 573-577.
[17] Aponte-Rueda M E, Saade Cárdenas R A, Saade Aure M J. Endoscopic axillary dissection: A systematic review of the literature[J]. The Breast, 2009, 18(3): 150-158.
[18] 骆成玉.乳腔镜腋窝淋巴结清扫术的应用解剖[J].首都医科大学学报,2007,28(1):39-41.
[19] 张书卿,刘训碧,张玲. 乳腺癌胸肌间淋巴结患者手术指征及手术治疗方法[J]. 中国煤炭工业医学杂志,2015,18(5):712-714.
[20] 刘春生,孙建伟,赖明华,贾玲. 腔镜辅助下背阔肌肌瓣乳腺癌肿瘤扩大切除乳房重塑25例临床观察[J]. 中华肿瘤防治杂志, 2013,20(17):1352-1355.

单孔法全腔镜局部扩大切除术进行保乳手术的临床应用

Single port laparoscopic breast-conserving surgery in treatment of breast cancer

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	赵越, 阮祥燕, 程姣姣, 谷牧青, 许新, 王月姣. 乳腺癌中PGRMC1表达与临床病理参数的相关性[J]. 首都医科大学学报, 2022, 43(3): 350-356.
[2]	魏常胜, 骆成玉, 张树琦. 环乳晕切口联合乳腔镜腋窝淋巴结清扫在早期乳腺癌保乳手术中的应用[J]. 首都医科大学学报, 2021, 42(6): 1014-1020.
[3]	中华预防医学会妇女保健分会; 中国人体健康科技促进会妇科内分泌与生育力促进专委会. 乳腺癌患者选择性雌激素受体调节剂治疗相关子宫内膜安全管理的中国专家共识(2021版)[J]. 首都医科大学学报, 2021, 42(4): 672-677.
[4]	阮祥燕, 杨瑜, 卢丹, 杜娟, 程姣姣, 谷牧青, 李扬璐, 金凤羽, 段微, 代荫梅, 鞠蕊, 许新, MatthiasKorell, AlfredO.Mueck. 中国首例乳腺癌患者冻存卵巢组织移植成功报道及文献复习[J]. 首都医科大学学报, 2021, 42(2): 177-182.
[5]	杨阳, 康骅, 赵菁, 凌煜玮, 赵烨, 王亚军, 戎冬冬. 术前乳腺MRI对乳腺癌保乳手术切缘评估的回顾性分析[J]. 首都医科大学学报, 2020, 41(6): 943-953.
[6]	王爱婷, 鄢丹, 齐宪荣. 包载多西他赛的聚合物胶束抑制小鼠乳腺癌转移作用研究[J]. 首都医科大学学报, 2020, 41(2): 225-230.
[7]	王维, 张紫寒, 翟妍, 桑翠琴, 王淑珍. 子宫体、乳腺双原发癌的临床病理特征[J]. 首都医科大学学报, 2019, 40(6): 857-862.
[8]	张蕴显, 王雅梅, 周萍. 乳腺癌中基于开放染色质的环状RNA互作网络构建及功能分析[J]. 首都医科大学学报, 2019, 40(6): 901-910.
[9]	白向东, 郝雅婷, 张欣雪, 贺强. 脾多肽注射液联合术后化疗对三阴性乳腺癌患者临床疗效的研究[J]. 首都医科大学学报, 2019, 40(6): 911-915.
[10]	张凌燕, 阮祥燕, 蔡桂举, 谷牧青, Alfred O. Mueck. 他莫昔芬治疗转染孕激素受体膜组分1乳腺癌裸鼠模型对乳腺肿瘤组织Ki-67表达的影响[J]. 首都医科大学学报, 2019, 40(4): 533-538.
[11]	王月姣, 阮祥燕, 谷牧青, 蔡桂举, 李雪, 张凌燕, Alfred O. Mueck. 他莫昔芬治疗乳腺癌异种移植瘤裸鼠子宫病理改变[J]. 首都医科大学学报, 2019, 40(4): 539-543.
[12]	白向东, 郝雅婷, 张欣雪, 贺强. 雌激素受体阳性和阴性乳腺癌术后辅助化学药物治疗中加用脾多肽的临床免疫疗效观察[J]. 首都医科大学学报, 2019, 40(3): 443-448.
[13]	陈妮娜, 范怡畅, 尚昆, 杨婧, 曹邦伟. 血清血脂及载脂蛋白浓度与乳腺癌分子分型及Ki-67表达水平的相关性研究[J]. 首都医科大学学报, 2019, 40(2): 191-194.
[14]	李雪, 阮祥燕, 谷牧青, 蔡桂举, 赵越, Alfred O. Meuck. 孕激素受体膜组分1促进雌孕激素诱导的乳腺癌细胞增生的研究——雌二醇与周期序贯及连续联合比较[J]. 首都医科大学学报, 2019, 40(2): 237-243.
[15]	徐泉, 刘玉洁, 潘钰, 郑秀瑗, 刘静民, 孙小花, 邹丽丽, 马丽娜, 严红松. 生物电阻抗测试频率对乳腺癌相关淋巴水肿定量评估的影响[J]. 首都医科大学学报, 2018, 39(5): 747-751.